UC Davis Medical Center’s Mind Institute was one of five institutes in the nation to win the NIH’s Autism Centers of Excellence Award (ACE). The $12 million, five year grant, will be used for the creation of the “Center for the Development of Phenotype-based Treatments of Autism Spectrum Disorder.” This new center will take a personalize approach to addressing autism spectrum disorder (ASD) treatment based on a child’s behavioral and biological characteristics. The goal will be to identify and tailor treatments that improve the quality of life for those with ASD.Read More
Tags: CA, Current Biotechnology Events, California, NIH funded Research Projects, Autism, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, drug evaluation, BioResearch Product Faire, autism research, Bioresearch Grant, Laboratory product sales, NIH awards 2017
The National Institute of Mental Health recently awarded a $2.3M Biobehavioral Research Award for Innovative New Scientists (BRAINS) grant to Dr. Matthew D. Lerner, an assistant professor in the Department of Psychology at Stony Brook University. The grant will provide funding for Dr. Lerner's project, “Optimizing Prediction of Social Deficits in Autism Spectrum Disorders,” a study which aims to help youth with autism overcome social challenges.
The National Institutes of Health (NIH) recently launched a new network of institutions - called the Centers for Common Disease Genomics (CCDG) - which will study common conditions such as heart disease, stroke, diabetes, and autism to see how genetics and DNA contribute to the risk of these diseases. The McDonnell Genome Institute at Washington University in St. Louis is one of four institutions involved in this network and will be receiving $60 million over the next four years to study genomics and common diseases.Read More
Tags: Washington University St. Louis, Midwest, Missouri, WashU, heart disease, Diabetes, Autism, BioResearch Product Faire Event, MO, St Louis, NIH funding, 2016, Centers for Common Disease Genomics, stroke, CCDG
University of California, San Diego School of Medicine is soon going to be home to the first clinical trials of a new treatment for Autism Spectrum Disorder (ASD), a condition that affects 1-2 percent of American children.Read More
Researchers at University of Pittsburgh Graduate School of Public Health report that they have associated exposure to air pollution from pregnancy through age 2 to an increased risk of childhood autism.Read More
Researchers at University of California, San Diego School of Medicine are now working with functional magnetic resonance imaging (fMRI) to predict language development in kids with autistic spectrum disorder (ASD).
Instances of autism have been rapidly increasing in the United States over the past few decades, with recent rates of affliction reported as high as 1 in 68 children. For many children affected by autism spectrum disorder (ASD), difficulties with language development are an unfortunate reality.Read More
This prestigious designation makes the MIND Institute one of only fifteen Intellectual and Developmental Disabilities Research Centers in the country. Transition into this program is made possible by a five-year $6.5 million NIH grant and gives the institute critical new resources that will accelerate its progress in neurodevelopment research.
Tags: University of California Davis Medical Center, Bioinformatics, neurodevelopmental disorders, assays, molecular biology imaging, biological analysis, immunoassays, environmental contaminants, Autism, UCDMC, Funding, Research, NIH, UC Davis, UCD, grant, drug evaluation, developmental disabilities
The NIH has just announced $5.3M in two new awards through the Autism Centers of Excellence (ACE) program to support autism research studies led by two University of California investigative teams, at UCLA and the UC Davis Medical Center MIND Institute. ACE funding is earmarked for large, multi-disciplinary studies into the origins of autism spectrum neurological disorders and avenues for their treatment. In the case of the two latest awardees, one is a clinical behavioral study and one is a study of genetic variants. The $5.3M is initial one-year funding, with extensions of up to five years. The ACE program includes both centers and networks. Centers are made up of multiple investigators at one site working together on a specific research problem; networks include investigative teams from different sites engaged in a focused study. Both UCLA and UC Davis are ACE centers and will lead the current research projects, though in collaboration with colleagues at other research institutions, namely Harvard, UW, Vanderbilt, Emory, Johns Hopkins, and Yale. As with all ACE research, data and findings are collected centrally by the NIH to maximize their availability to the larger research community.
Tags: 2014, CA, 2013, Southwest, Los Angeles, Autism, LAVS, UCDMC, BioResearch Product Faire Event, Funding, UCLA, Genetics, Research, Sacramento, Davis, NIH funding, UC Los Angeles, UC Davis, Biotechnology Vendor Showcase Event